Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

China flag China · Delayed Price · Currency is CNY
9.94
+0.14 (1.43%)
Mar 10, 2026, 3:00 PM CST
19.33%
Market Cap 4.36B
Revenue (ttm) 2.39B
Net Income (ttm) -29.25M
Shares Out 438.41M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE 58.47
Dividend 0.20 (2.04%)
Ex-Dividend Date Sep 12, 2025
Volume 4,962,864
Average Volume 7,077,339
Open 9.80
Previous Close 9.80
Day's Range 9.80 - 9.99
52-Week Range 7.44 - 12.82
Beta 0.71
RSI 44.32
Earnings Date Apr 30, 2026

About SHA:603520

Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical raw materials in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadobenate dimeglumine injections; contrast agent APIs and intermediates consisting of iohexol, iopamidol, iodixanol, ioversol, iopromide, iomeprol, gadobenat... [Read more]

Sector Healthcare
Founded 1997
Employees 1,754
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.